Patients (n = 25) and tumor characteristics
| Characteristic | n | % |
| Age at diagnosis (years) | ||
| Median | 69 | |
| Range | 55–91 | |
| BMI (median) (kg/m2) | 30 | |
| <30 | 12 | 48 |
| 30–40 | 9 | 36 |
| >40 | 4 | 16 |
| Pre-operative imaging studies | ||
| CT scan of abdomen and pelvis | 12 | 48 |
| Ultrasound of abdomen and pelvis | 12 | 48 |
| Unknown | 1 | 4 |
| Histology (on pre-operative endometrial biopsy) | ||
| High-grade carcinoma | 18 | 72 |
| Endometrioid grade 1 | 3 | 12 |
| Endometrial Intraepithelial neoplasia | 4 | 16 |
| Histology (on final pathology) | ||
| Serous | 15 | 60 |
| Mixed | 4 | 16 |
| Grade 3 endometrioid | 3 | 12 |
| Clear cell | 2 | 8 |
| Carcinosarcoma | 1 | 4 |
| Polyp | ||
| Yes | 10 | 40 |
| No | 15 | 60 |
| Lymphovascular space invasion | ||
| Yes | 4 | 16 |
| No | 21 | 84 |
| CA-125 (units/mL) | ||
| Median | 24 | |
| Range | 5–326 | |
| Surgical approach | ||
| Robotic surgery | 12 | 48 |
| Laparoscopic surgery | 10 | 40 |
| Laparotomy | 3 | 12 |
| Surgical staging | ||
| SLN + pelvic lymphadenectomy | 19 | 76 |
| SLN + pelvic and para-aortic lymphadenectomy | 3 | 12 |
| SLN only | 3 | 12 |
| Omentectomy | 4 | 16 |
| Follow-up (months) | ||
| Median | 44 | |
| Range | 2–67 | |
BMI, body mass index; CT, computed tomography; SLN, sentinel lymph node.